A new year means a new Fierce Biotech Fundraising Tracker to record the significant amounts of venture capital being funneled into the industry. We're maintaining the criteria we used for last ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

View today's HOB Biotech Group Corp Ltd stock price and latest 688656 news and analysis. Create real-time notifications to follow any changes in the live stock price.

Concord Biotech, operating in the Pharmaceuticals sector and classified as a Smallcap on the BSE, currently has its share price at ₹1541. The stock has experienced fluctuations today ...

Xiamen Amoytop Biotech Co Ltd stock price live, this page displays SS 688278 stock exchange data. View the 688278 premarket stock price ahead of the market session or assess the after hours quote.

Rossari Biotech, operating in the Chemicals - Speciality sector and classified as a Smallcap on the BSE, currently has its share price at ₹658.4. The stock has experienced fluctuations today ...

To The Members of Indrayani Biotech Limited. Your directors are pleased to present the Thirty Second (32 nd) Annual Report of the Company together with the audited financial statements (standalone ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Sinovac Biotech Ltd. (SVA) Follow Add holdings 6.47 0.00 (0.00%) At close: April 1 at 4:00:00 PM EDT Income Statement Balance Sheet Cash Flow Dividends Currency in USD All numbers in thousands ...

Intellia Therapeutics has said it will reduce its headcount by 27% this year and shelve early-stage R&D programmes as it puts its resources behind two priority drug candidates. The specialist in ...